Détail du document
Identifiant

oai:arXiv.org:2403.15443

Sujet
Electrical Engineering and Systems... Computer Science - Artificial Inte... Computer Science - Computer Vision... Computer Science - Machine Learnin... Electrical Engineering and Systems...
Auteur
Borji, Arezoo Hejazi, Taha-Hossein Seifi, Abbas
Catégorie

Computer Science

Année

2024

Date de référencement

03/04/2024

Mots clés
disease progressive impairment mild deep-learning cognitive models alzheimer computer science
Métrique

Résumé

Alzheimer's disease is a progressive neurodegenerative disorder that primarily affects cognitive functions such as memory, thinking, and behavior.

In this disease, there is a critical phase, mild cognitive impairment, that is really important to be diagnosed early since some patients with progressive MCI will develop the disease.

This study delves into the challenging task of classifying Alzheimer's disease into four distinct groups: control normal (CN), progressive mild cognitive impairment (pMCI), stable mild cognitive impairment (sMCI), and Alzheimer's disease (AD).

This classification is based on a thorough examination of PET scan images obtained from the ADNI dataset, which provides a thorough understanding of the disease's progression.

Several deep-learning and traditional machine-learning models have been used to detect Alzheimer's disease.

In this paper, three deep-learning models, namely VGG16 and AlexNet, and a custom Convolutional neural network (CNN) with 8-fold cross-validation have been used for classification.

Finally, an ensemble technique is used to improve the overall result of these models.

The results show that using deep-learning models to tell the difference between MCI patients gives an overall average accuracy of 93.13% and an AUC of 94.4%.

Borji, Arezoo,Hejazi, Taha-Hossein,Seifi, Abbas, 2024, Introducing an ensemble method for the early detection of Alzheimer's disease through the analysis of PET scan images

Document

Ouvrir

Partager

Source

Articles recommandés par ES/IODE IA

MELAS: Phenotype Classification into Classic-versus-Atypical Presentations
presentations mitochondrial strokelike patients variability phenotype clinical melas
Protocol for the promoting resilience in stress management (PRISM) intervention: a multi-site randomized controlled trial for adolescents and young adults with advanced cancer
cancer quality of life anxiety depression hope coping skills communication intervention randomized ayas outcomes resilience care trial cancer prism-ac advanced